tm logo
ACCRETAMAB
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 20 May 2022

Last Applicant/ Owned by

1-9-2, OTEMACHI, CHIYODA-KU

TOKYO

JP

Serial Number

86643143 filed on 27th May 2015

Registration Number

4851400 registered on 10th Nov 2015

in the Principal Register

Correspondent Address

KAUSHAL ODEDRA

Odedra Law Office Pllc

2020 Pennsylvania Ave NW # 152

Washington, DC 20006-1811

Filing Basis

1. intent to use

Disclaimer

NO DATA

ACCRETAMAB

Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, caRead More

Classification Information


Class [005]
Pharmaceutical Products


Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

Mark Details


Serial Number

No 86643143

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM15-550

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th May 2022CANCELLED SEC. 8 (6-YR)
10th Nov 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04th Sep 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10th Nov 2015REGISTERED-PRINCIPAL REGISTER
25th Aug 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25th Aug 2015PUBLISHED FOR OPPOSITION
05th Aug 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Jul 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
21st Jul 2015APPROVED FOR PUB - PRINCIPAL REGISTER
20th Jul 2015TEAS/EMAIL CORRESPONDENCE ENTERED